In conclusion, the present study has provided novel insights into the molecular mechanism through which MAFG-DT promotes PCa cell proliferation, invasion, migration, and bone metastasis, suggesting that MAFG-DT may serve as a promising therapeutic target against PCa bone metastasis. This evidence concerns the gene MAFG and posterior cortical atrophy.